These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin]. Guillemin R, Fontaine M. C R Acad Hebd Seances Acad Sci D; 1975 May 26; 280(20):2353-6. PubMed ID: 807423 [Abstract] [Full Text] [Related]
3. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus. Unger RH, Orci L. Annu Rev Med; 1977 May 26; 28():119-30. PubMed ID: 324351 [No Abstract] [Full Text] [Related]
4. Pancreatic alpha cell function in man. Nutr Rev; 1971 Jan 26; 29(1):8-10. PubMed ID: 4950201 [No Abstract] [Full Text] [Related]
5. Regulation of glucagon secretion of the diabetic pancreas in vitro [proceedings]. Matschinsky FM, Pagliara AS. Metabolism; 1976 Nov 26; 25(11 Suppl 1):1517. PubMed ID: 135912 [No Abstract] [Full Text] [Related]
6. Approaches to novel antidiabetic therapy. Petrack B, Czernik AJ, Cassidy JP. Trans N Y Acad Sci; 1983 Nov 26; 41():147-60. PubMed ID: 6152686 [No Abstract] [Full Text] [Related]
7. Evidence for an insulin-independent alpha-cell abnormality in human diabetes. Bennett PH, Aronoff SL, Unger RH. Metabolism; 1976 Nov 26; 25(11 Suppl 1):1527-9. PubMed ID: 790099 [No Abstract] [Full Text] [Related]
8. Somatostatin. Physiology and clinical applications. Gerich JE, Patton GS. Med Clin North Am; 1978 Mar 26; 62(2):375-92. PubMed ID: 347198 [No Abstract] [Full Text] [Related]
11. Somatostatin and diabetes. Gerich JE. Am J Med; 1981 Mar 26; 70(3):619-26. PubMed ID: 6111219 [Abstract] [Full Text] [Related]
12. The effects of epinephrine on islet hormone secretion in the dog. Ahrén B, Veith RC, Taborsky GJ. Int J Pancreatol; 1988 Jul 26; 3(5):375-88. PubMed ID: 2902147 [Abstract] [Full Text] [Related]
13. The role of glucagon-insulin interactions in control of glucose turnover and its significance in diabetes. Vranic M, Ross G, Doi K, Lickley L. Metabolism; 1976 Nov 26; 25(11 Suppl 1):1375-80. PubMed ID: 790086 [No Abstract] [Full Text] [Related]
14. Organ culture of isolated rat pancreatic islets with reference to A-cell function. Lorenz RA, Sharp RA, Kasselberg AG, Burr IM. Diabetes Res; 1985 May 26; 2(3):157-61. PubMed ID: 2866058 [Abstract] [Full Text] [Related]
15. Investigations on isolated islets of langerhans in vitro. 16.Modification of the glucose-dependent inhibition of glucagon secretion. Hahn HJ, Ziegler M. Biochim Biophys Acta; 1977 Oct 25; 499(3):362-72. PubMed ID: 334269 [Abstract] [Full Text] [Related]
16. Insulin and glucagon secretion from rat islets maintained in a tissue culture-perifusion system. Gingerich RL, Aronoff SL, Kipnis DM, Lacy PE. Diabetes; 1979 Apr 25; 28(4):276-81. PubMed ID: 374172 [Abstract] [Full Text] [Related]
17. Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man. Goldsmith SJ, Yalow RS, Berson SA. Diabetes; 1970 Jun 25; 19(6):453-7. PubMed ID: 4393032 [No Abstract] [Full Text] [Related]
18. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum. Honey RN, Schwarz JA, Mathe CJ, Weir GC. Am J Physiol; 1980 Feb 25; 238(2):E150-6. PubMed ID: 6444782 [Abstract] [Full Text] [Related]
20. Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell function. Itoh M, Mandarino L, Gerich JE. Diabetes; 1980 Sep 25; 29(9):693-6. PubMed ID: 6160072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]